INTRODUCTION
In the livers of several species, a membrane receptor is found for prolactin (Posner et al., 1974; Gertler et al., 1984; Waters et al., 1984; Haro & Talamantes, 1985) . Previous studies in our laboratory indicated the presence of a lactogenic hormone-binding species in detergentsolubilized crude membrane fractions from female rat liver with an Mr of about 80000-90000 (Haldosen & Gustafsson, 1987) . This molecular species was shown to contain Mr40000 and -35000 hormone-binding subunits. From those studies we could not determine whether the subunits were combined with each other or with additional subunit(s) to make up the Mr-80000-90000 species.
Ovary and Leydig cell preparations from rat both contain a lactogenic hormone-binding entity with an Mr of about 80000 (Bonifacino & Dufau, 1984 . In both tissues this molecular species was shown to contain a hormone-binding subunit with an Mr of about 40000. Three binding species with Mr values of 95000, 86000 and 43000 have been identified in rat liver for the prolactin-related hormone, growth hormone (Husman et al., 1988) . The Mr-43000 species was found to be a constituent of the Mr-86000 species. In mouse liver, three immunologically related growth-hormone-binding species with Mr values of 101000, 40700 and 37500 have been identified (Smith et al., 1988) . Recently Boutin et al. (1988) have cloned cDNA encoding the rat liver Mr-41 000 prolactin receptor. The amino acid sequence deduced from the cDNA sequence was shown to have strong localized sequence identity with the earlier published amino acid sequence of the rabbit and human growth hormone receptors (Leung et al., 1987) .
Specific lactogenic binding activity has been found in plasma membrane-enriched, Golgi-enriched and lysosome-enriched fractions prepared from rat liver (Norstedt et al., 1984; Borst et al., 1985) . Affinity cross-linking studies revealed the presence of an Mr-36000 lactogenic hormone-binding entity in plasma membrane-and Golgienriched fractions (Borst et al., 1985) .
Rat or mouse liver receptor and rat ovarian receptor have been shown to be retained on and specifically eluted from lectin-chromatography gel (Costlow & Gallagher, 1979; Bhattacharya & Vonderhaar, 1981; Kusuda & Dufau, 1986; Mitani & Dufau, 1986) . Furthermore, the inhibition by lectins of the binding of lactogenic hormones to rat and mouse liver receptors (Costlow & Gallagher, 1977 , 1979 Bhattacharya & Vonderhaar, 1981) indicate that carbohydrate chains are linked to the receptor. The deduced amino acid sequence from the recently cloned prolactin receptor cDNA revealed three potential asparagine glycosylation sites (Boutin et al., 1988) . By treating rats with the glycosylation inhibitor Abbreviations used: AP preparation, acid-precipitated preparation; bGH, bovine growth hormone; CMF, crude membrane fraction; DSS, disuccinimidyl suberate; Endo F and H, endo-,f-N-acetylglucosaminidase F and H (Savoie et al., 1986) .
In an attempt to elucidate the type(s) of carbohydrate chains linked to the different lactogen hormone-binding species in rat liver, we have undertaken an investigation involving analysis of glycosidase-treated, covalently cross-linked 125I-labelled human growth hormone (hGH)-receptor complex on SDS/polyacrylamide-gel electrophoresis (PAGE). Subcellular fractions of rat liver have also been investigated with respect to presence and type of '25I-hGH-binding species.
MATERIALS AND METHODS

Materials
Virgin and late pregnant female Sprague-Dawley rats (Anticimex, Stockholm, Sweden), 8-10 and 11-13 weeks of age respectively, were used throughout the study.
Virgin rats were injected with 17,f-oestradiol-valerate in order to increase the concentration of liver lactogen receptor (Haldosen & Gustafsson, 1987) . In some experiments, rats were injected with '25I-labelled ovine prolactin (oPRL) (see legend to Fig. 6 ). Biosynthetic methionyl somatotropin (Somatonorm; 2 units/mg) was a gift from AB Kabi (Stockholm, Sweden). Ovine prolactin (NIADDK-oPrl-16) and bovine growth hormone (bGH) (NIH-GH-B-14) were obtained from the Hormone Distribution Program (National Institute of Arthritis, Metabolism and Digestive Diseases, NIH, Bethesda, MD, U.S.A.). 125I-hGH and 125I-oPRL were prepared by the lodogen method (Fraker & Speck, 1978) . For a detailed description see Haldosen & Gustafsson (1987 Haldosen & Gustafsson (1987) . Preparation of crude membrane fraction and hepatic subcellular fractions Crude membrane fraction (CMF) was prepared as described earlier (Haldosen & Gustafsson, 1987) . This membrane preparation has been characterized by enzyme-marker analysis (Andersson et al., 1978 , 1986) . In brief, the RMF predominantly consists of vesicles derived from the rough and smooth endoplasmic reticulum and exhibits a 2-3-fold relative enrichment (on a protein basis) of the endoplasmic reticulum marker NADPH-cytochrome c reductase compared with a total particulate fraction. The enrichment values for fluoridestimulated adenylate cyclase (blood-sinusoidal plasma membrane), tartrate-sensitive acid phosphatase (lysosomes) and UDP-galactosyltransferase using N-acetylglucosamine as acceptor (Golgi complex) in the RMF are 1.3-, 0.6-and 1.0-fold respectively. Thus, a minor contamination of plasma membrane-derived vesicles in this fraction cannot be excluded. Marker-enzyme analysis of IMF demonstrates a 3-, 6-and 16-fold enrichment of NADPH-cytochrome c reductase, adenylate cyclase and galactosyltransferase respectively, with no enrichment (< 1) of acid phosphatase. The LDMF is a pool of Golgi cisternae and vesicles in addition to secretory vacuoles (Eriksson et al., 1986) and endocytic vesicles (Engfeldt & Andersson, 1987) . This fraction exhibits a 40-50-fold enrichment of galactosyltransferase activity, a 10-fold increase in adenylate cyclase activity and no enrichment in acid phosphatase or NADPH-cytochrome c reductase activity. Plasma membrane-fraction (PMF), mainly consisting of the bile canalicular domain but also the bloodsinusoidal domain, were prepared by the method of Song et al. (1969) . The enrichment of fluoride-stimulated adenylate cyclase is about 20-fold compared with the homogenate. The lysosomal fractions 1 and 2 (LI, L2) were isolated by the method of Wattiaux et al. (1978) . Morphological analysis of the LI fraction shows a large proportion of lipoprotein-filled endocytic vacuoles, in addition to typical secondary lysosomes/dense bodies (Khan et al., 1981; Ferland et al., 1984) . Marker-enzyme analysis demonstrates a 2.4-, 10-and 2.5-fold enrichment of galactosyltransferase, acid phosphatase and adenylate cyclase activities respectively. The L2 fraction contains mature or secondary lysosomes and is 20-fold enriched in acid phosphatase, with no enrichment of galactosyltransferase or adenylate cyclase activities. Solubilization of hepatic membranes and precipitation of solubilized crude membrane proteins For a detailed description of solubilization of hepatic membranes and preparation of acid-precipitated solubilized crude membrane proteins (AP preparation) see Haldosen & Gustafsson (1987) . Binding and cross-linking of iodinated hormone to membranes and to solubilized and redissolved acidprecipitated extracts
Aliquots of membranes and of AP preparation were incubated with 125I-hGH for 18-20 h at 20°C in the absence or presence of unlabelled hGH. Detailed information concerning incubation parameters is found in legends to Figures. Cross-linking was performed with disuccinimidyl suberate (DSS) as earlier described (Haldosen & Gustafsson, 1987) .
Aliquots of 125I-hGH-incubated and cross-linked CMF containing 150 ,ug of protein were pipetted into Eppendorf minifuge tubes. After centrifugation at 10000 g for 20 min in an Eppendorf minifuge centrifuge, the pellet was resuspended with 75 added. In order to remove excess SDS, the samples were left to stand overnight at 4 'C and then centrifuged in an Eppendorf minifuge centrifuge at 10000 g for 15 min. Electrophoresis and autoradiography For a detailed description of SDS/PAGE of crosslinked samples performed according to the method of Laemmli (1970) and autoradiography, see Haldosen & Gustafsson (1987) .
RESULTS
We have used biosynthetic methionyl somatotropin (Mr-22 500), here designated hGH, for labelling of specific lactogenic binding sites in different preparations offemale rat liver. hGH has earlier been shown to bind to both lactogenic and somatogenic binding sites in rat liver (Ranke et al., 1976) .
The crude membrane fraction of rat liver is a mixture of membranes with different subcellular origins (see the Materials and methods section) and has either been used as membrane (M), Triton X-100-solubilized or redissolved, acid-precipitated Triton X-100-solubilized (AP) preparation. With an affinity cross-linking technique, we have earlier shown the presence of specific 125J-hGH binding entities in these preparations with apparent Mr of 40000 (M), 87000, 40000, 35000 and 32000 (Triton X-100-solubilized), and 87000, 40000 and 35000 (AP) (Haldosen & Gustafsson, 1987 . The Mr-87000, -40000 and -35000 binding sites and the Mr-32000 binding site displayed specific lactogenic and somatogenic binding activities respectively. Further analysis of different membrane preparations has since yielded the following apparent Mr values for the specific '25I-hGH binding entities: 82200 (S.D.+4900; n = 31), 40600 (+1700; n=39), 35600 (+1300; n=27) and 31500 (+1400; n= 8). The N-glycanase activity of a commercial preparation containing both EndoF and N-glycanase activity was used to remove all types of asparagine-linked glycans (Tarentino et al., 1985) . Plummer et al. (1984) have shown that these enzymes have different pH optima (Endo F, pH 4-6; N-glycanase, pH 8-9). In our hands and when working according to the instructions of the manufacturers, no Endo F activity was seen at pH 4 (results not shown). At pH 9, a clear effect on the electrophoretic mobility of cross-linked entities was seen (Fig. 1) . In the AP preparation, a decrease in molecular mass was seen for all binding species. The Mr-104000, -62000 and -57000 complexes, which represent Mr-82000, -40000 and -35000 binding species respectively, were decreased by Mr-10000, -10000 and -5000 respectively. Incubated and cross-linked M preparation, subjected to N-glycanase treatment, showed a 10000 shift in Mr for the Mr-62000 complex (results not shown).
The mean values for the shifts were: Mr-104000 complex, 10200 (n = 3); M,-62000 complex, 10900 (n = 9) and Mr-57000 complex, 5600 (n = 4). From these experiments, it was concluded that the lactogenic hormonebinding entities contain N-linked oligosaccharide chains. The appearance of Mr404000 and -57000 complexes in AP preparations is due to exposure of lactogenic hormone-binding sites by detergent treatment.
In order to remove biantennary complex (Endo F) and hybrid and high-mannose (Endo F, Endo H) chains (Tarentino et al., 1985) which are possibly present on hormone-binding species, cross-linked AP preparation was treated with a highly purified Endo F preparation (results not shown) and Endo H (Fig. 2) . A decrease in Mr of 5000 was seen for the M,-57000 complex (Mr-35000 binding entity) (Fig. 2, lanes a and c) . The and a minor part of the Mr-82000 (Mr-104000 complex) lactogen hormone-binding species contain high-mannose chains. From these experiments, it could also be concluded that the MrA40000 (Mr-62000 complex) and the major part of the Mr-82000 hormone-binding species have tri-or tetra-antennary complex (and not biantennary complex), hybrid or high-mannose oligosaccharide chains linked to the protein backbone.
Since complex oligosaccharide chains often contain sialic acids (Sharon & Lis, 1982) we investigated whether this was the case with the complex chains of the Mr-40000 and the major part of Mr-82000 entities. Fig. 3 shows the results of neuraminidase treatment of crosslinked M and AP preparations (Fig. 3, lanes a- Cross-linked RMF was shown to contain Mr-62000, -57000 and -54000 complexes (Fig. 4, lanes a and b) (Fig. 4, lanes c and d) or Triton X-100-solubilized (results not shown) preparations. Detergent-solubilized and cross-linked IMF, run on SDS/PAGE under nonreducing conditions, contained an additional Mr-104000 complex (results not shown). Major complexes with Mr values of 104000 and 62000 were detected when the LDMF was analysed. Low amounts of Mr-57000 and -54000 complexes were also present. This pattern was the same whether membrane (Fig. 4, lanes e and f) or Triton X-100-solubilized (results not shown) LDMFs were analysed. In membrane (Fig. 4, lanes g and h) or Triton X-100-solubilized (results not shown) preparations of PMF, an Mr-62 000 complex and, on prolonged exposure of X-ray film (results not shown), an Mr-57000 complex were detected. When SDS/PAGE was run under nonreducing conditions, no additional complex was detected.
The lysosome/endosome-and lysosome-enriched fractions LI and L2 (see the Materials and methods section) were analysed as membrane preparation with respect to the presence of specific '251-hGH-binding species (Fig. 5) .
Vol. 263 In both fractions, a diffuse broad band representing complexes with M, values between 62000 and 57000 was detected (Fig. 5, lanes c-f) . Triton X-100-solubilized and cross-linked LI and L2 fractions, run on SDS/PAGE under non-reducing conditions, showed no additional complexes (results not shown). Analysis of cross-linked endosomal lactogenic receptors in LDMF, prepared from rats injected with 125I-oPRL and killed after 10 min, showed a complex with an M, value of 62000 (Fig. 6,   lane a) . The lactogenic hormone-binding specificity of this species was controlled by co-injection with the tracer, in separate animals, of either unlabelled oPrl or unlabelled bGH (Fig. 6, lanes b and c respectively) .
DISCUSSION
The deglycosylation experiments indicate that two populations of Mr-82000 species exist (Figs. 7c and 7d) . The Mr value of 82000 probably represents the most abundant entity containing the Mr40000 subunit, whereas the less abundant Mr-82 000 binding species containing the Mr-35000 subunit is probably found in the lower part of the autoradiographic band. Perhaps a carefully designed gradient gel could resolve these two entities. Below we will still use the term Mr-82 000 species to designate both populations of binding entities. The deglycosylation experiments also conclude that the Mr-82000 species is not composed of two identical subunits. A homodimer of Mr-40000 species would be decreased by 20000 in Mr by the action of N-glycanase. A heterodimer of Mr-40000 and Mr-35 000 species would decrease by 15000 in Mr. Thus, the Mr-40000 and Mr-35000 subunits each appear to be combined with a subunit(s) not visualized with affinity cross-linking (Figs.  7c and 7d) . Following the action of N-glycanase, the decrease in Mr is 10000 for both Mr-82000 and Mr-40000 species. This indicates that the undetected subunit(s) is probably not glycosylated.
The lactogenic Mr-35000 and somatogenic Mr-32000 hormone-binding species were both detected in the RM fraction. This fraction had to be solubilized prior to incubation in order to label these species. This suggests that the binding sites are found on the luminal side of the membrane vesicles. Furthermore, the fact that the Mr-32000 species was not found in the plasma membraneenriched fraction suggests that the Mr-35000 and -32000 species seen in the RM fraction are situated in vesicles derived from endoplasmic reticulum and not in plasma membrane vesicles contaminating this fraction. Low amounts of the Mr-40000 species were detected in membrane and detergent-solubilized preparations of the RM fraction. Thus, the binding site of this entity appears to be exposed to the exterior of the membrane vesicles. This makes it reasonable to assume that the MrA40000 species is located on plasma membrane vesicles that are present as a contaminant in the RM fraction.
The Mr-40000 species was clearly detectable and the Mr35 000 and -32000 species weakly detectable in membrane and Triton X-100-solubilized preparations of IMF and LDMF which were enriched in Golgi vesicles. When crude membrane preparations of rat liver are analysed, the Mr-35000 and -32000 species are detected only when this preparation is solubilized by Triton X-100 prior to incubation (Haldosen & Gustafsson, 1987 ). An explanation for the detection of the Mr-35000 and -32000 but also the Mr-40000 species in membrane preparations of IMF and LDMF could be that vesicles are disrupted during preparation, resulting in exposure of binding sites. By use of electron microscopy, it has earlier been demonstrated that LDMF contains disrupted Golgi vesicles when this fraction is sedimented and resuspended . The Mr,40000 and -35000 but not the Mr-32000 species were also detected in membrane and Triton X-100-solubilized preparations of plasma membrane-enriched fractions.
The facts that (1) (Glc3MangGlcNAc2) which is co-translationally added in the lumen of the endoplasmic reticulum to the newly synthesized protein backbone (Sharon & Lis, 1982) . By the action of very specific glycosidases and glycosyltransferases, the conversion of high-mannose chains to complex chains starts in the endoplasmic reticulum and proceeds further in the different Golgi compartments. The carbohydrate chain is rendered Endo H-insensitive by the action of the mannosidase II, the action of which is believed to be restricted to the medial Golgi cisternae (Dunphy & Rothman, 1985) . Thus, our results indicate that a minor fraction of the Mr-35000 species escapes the action of the abovementioned medial Golgi enzyme. Tauber et al. (1986) have studied the glycosylation of an Mr-80000 rat liver glycoprotein which is partly inserted into the plasma membrane and partly secreted into the serum. The serum form of this protein is glycosylated with complex-type oligosaccharides and the plasma membrane form has high-mannose glycans. Thus the Golgi complex may process one and the same glycoprotein differently.
In the endosome/lysosome (Ll)-and lysosome (L2)-enriched fractions, a broad autoradiographic band was seen. The M, values of the hormone-binding entities giving rise -to this band were calculated to be between 35000 and 40000. This finding might be explained by the presence of 'binders' in different stages of degradation (Tauber et al., 1983) . The cross-linking of injected and endocytosed 125I-oPRL in vivo to a single binding species with an Mr value of 40000 in LDMF and, furthermore, the short labelling time used (10 min) suggest that the Mr40000 species, which is not complexed with undetected subunit(s) (see below) is found in early endosomes which are present in LDMF Engfeldt & Andersson, 1987) .
The Mr-82000 species was only detected in the Golgienriched fractions IMF and LDMF. Detection of this hormone-binding entity in IMF required detergent solubilization and that SDS/PAGE was run in the absence of reductant. Surprisingly, the Mr-82000 species was detected in LDMF without prior detergent solubilization. This is in contrast to the conditions needed for detection of this species in crude membrane fraction. In our earlier study (Haldosen & Gustafsson, 1987) 
